Opinion: SBA's reinterpretation halts many biotech research grants

09/7/2005 | San Diego Source (subscription required)

The Small Business Administration's reinterpretation of investor ownership requirements -- which now excludes any company more than 51% owned by venture capital firms -- has halted many biotech companies' research progress by preventing them from attaining Small Business Innovation Research grants. Dr. Elias A. Zerhouni, director of the National Institutes of Health, has appealed to SBA to reconsider the limitations, and two bills regarding this issue have been introduced to Congress.

View Full Article in:

San Diego Source (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC